钠-葡萄糖耦联转运体2抑制剂的药物基因组学研究进展 点击下载
论文标题: | 钠-葡萄糖耦联转运体2抑制剂的药物基因组学研究进展 |
英文标题: | |
中文摘要: | 钠-葡萄糖耦联转运体2抑制剂(SGLT2i)是一类新型口服降糖药物,广泛应用于2型糖尿病患者的降糖治疗,但由于患者的遗传背景差异,常导致药物治疗的反应性多样。本文通过综述SGLT2i的药物基因组学研究报道,发现UGT1A9、UGT2B4、SLC5A2、ABCB1、PNPLA3、WFS1基因变异可能影响SGLT2i的药代动力学以及SGLT2i在改善非酒精性脂肪性肝病、减重等方面的降糖外效应,但尚无足够的临床证据支持基因多态性影响SGLT2i的降糖疗效。 |
英文摘要: | Sodium-glucose linked transporter 2 inhibitors(SGLT2i) are novel oral hypoglycaemic agents and are widely used for hypoglycemic therapy in patients with type 2 diabetes mellitus, but differences in the genetic backgrounds of patients often lead to variable responsiveness to drug therapy. By summarizing the pharmacogenomic studies of SGLT2i, the article found that the genetic variants of UGT1A9, UGT2B4, SLC5A2, ABCB1, PNPLA3 and WFS1 may influence the pharmacokinetics of SGLT2i and the external hypoglycemic effects of SGLT2i in improving non-alcoholic fatty liver disease, weight loss and so on, but there is no clinical evidence that genetic polymorphisms affect the hypoglycemic efficacy of SGLT2i. |
期刊: | 2024年第35卷第14期 |
作者: | 庄永如;宋金方 |
英文作者: | ZHUANG Yongru,SONG Jinfang |
关键字: | 基因多态性;钠-葡萄糖耦联转运体2抑制剂;个体差异;药物基因组学;药代动力学;药效动力学 |
KEYWORDS: | gene polymorphism; SGLT2i; individual differences; pharmacogenomics; pharmacokinetics; pharmacodynamics |
总下载数: | 81次 |
本日下载数: | 2次 |
本月下载数: | 81次 |
文件大小: | 619.60Kb |
* 注:未经本站明确许可,任何网站不得非法盗链资源下载连接及抄袭本站原创内容资源!在此感谢您的支持与合作!